Cargando…
Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials
BACKGROUND: Colchicine, an anti-inflammatory drug is prescribed nowadays for COVID-19. In this meta-analysis, we evaluated efficacy and safety of colchicine in patients with COVID-19. METHODS: We searched databases for randomised controlled studies evaluating efficacy and/or safety of colchicine as...
Autores principales: | Mehta, Kedar Gautambhai, Patel, Tejas, Chavda, Paragkumar D, Patel, Parvati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561824/ https://www.ncbi.nlm.nih.gov/pubmed/34810227 http://dx.doi.org/10.1136/rmdopen-2021-001746 |
Ejemplares similares
-
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
por: Lopes, Maria Isabel, et al.
Publicado: (2021) -
Efficacy and safety of lopinavir-ritonavir in COVID-19: A systematic review of randomized controlled trials
por: Patel, Tejas K., et al.
Publicado: (2021) -
Stigma, Discrimination, and Domestic Violence Experienced by Women Living with HIV: A Cross-sectional Study from Western India
por: Mehta, Kedar G., et al.
Publicado: (2019) -
Process evaluation of child health services at outreach sites during health and nutrition day (Mamta Day) in urban slums of Western India
por: Mehta, Kedar, et al.
Publicado: (2017) -
Screening Vaccinees for Non-Communicable Diseases and Risk Factors at a Covid-19 Vaccination Center in Vadodara, Gujarat
por: Chavda, Paragkumar D., et al.
Publicado: (2022)